[1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64 Suppl 2: ii18-ii23. DOI: 10.1136/ard.2004.03321710.1136/ard.2004.033217]Open DOISearch in Google Scholar
[2. Erkek E. Psoriazis Etyopatogenezi. Turkiye Klinikleri J Dermatol-Special Topics. 2008;1(3):1-14.]Search in Google Scholar
[3. Roman II, Orasan MS, Coneac A, Marina EM, Pop AD, Orasan RI. Genetic and Hormonal Determinations in a Pair of Identical Twins with Early Onset Psoriasis Vulgaris: Case Report and a Brief Review of the Literature. Rev Romana Med Lab. 2017; 25(3):287-94 DOI: 10.1515/rrlm-2017-002110.1515/rrlm-2017-0021]Open DOISearch in Google Scholar
[4. Oskay T, Erdem C. Apopitoz ve Dermatolojideki Önemi. Turkiye Klinikleri J Dermatol. 2000;10(3):213-21.]Search in Google Scholar
[5. Ada S. Psoriazis Sistemik Bir Hastalık mıdır? Turkiye Klinikleri J Dermatol-Special Topics. 2008;1(3):45-8.]Search in Google Scholar
[6. Oskay T, KundakçI N. Psoriasisde genetik bulgular. Turkiye Klinikleri J Dermatol. 2000;10(2):139-45.]Search in Google Scholar
[7. Asgari R, Yari K, Mansouri K, Bakhtiari M. Association analysis of FAS -670 A/G and FASL -844 C/T polymorphisms with risk of generalized agressive periodontitis disease. Biomed Rep. 2018;8 (4): 391-395.10.3892/br.2018.1060]Search in Google Scholar
[8. Ozdemirkiran FG, Nalbantoglu S, Gokgoz Z, Payzin BK, Vural F, Cagiran S, Berdeli A. FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders. Arch Med Sci. 2017;13(2): 426-432. DOI: 10.5114/aoms.2015.5396310.5114/aoms.2015.53963]Search in Google Scholar
[9. Gilhar A, Yaniv R, Assy B, Serafimovich S, Ull-mann Y, Kalish RS. Fas pulls the trigger on psoriasis. Am J Pathol. 2006;168(1):170-5. DOI: 10.2353/aj-path.2006.04135410.2353/aj-path.2006.041354]Open DOISearch in Google Scholar
[10. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281(5381):1305-8. DOI: 10.1126/science.281.5381.130510.1126/science.281.5381.1305]Search in Google Scholar
[11. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81(6):935-46. DOI: 10.1016/0092-8674(95)90013-610.1016/0092-8674(95)90013-6]Open DOISearch in Google Scholar
[12. Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol. 1997;34(8-9):577-82. DOI: 10.1016/S0161-5890(97)00081-310.1016/S0161-5890(97)00081-3]Open DOISearch in Google Scholar
[13. Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J, et al. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol. 2002;29(6):1183-8.]Search in Google Scholar
[14. Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC, et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol. 2003;170(1):132-8. DOI: 10.4049/jimmunol.170.1.13210.4049/jimmunol.170.1.13212496392]Search in Google Scholar
[15. Seishima M, Seishima M, Takemura M, Saito K, Kitajima Y. Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis. Dermatology. 1998;196(3):371-2.]Search in Google Scholar
[16. Mysliwiec H, Baran A, Mysliwiec P, Gorska M, Flisiak I. Upregulation of the sFas/sFasL system in psoriatic patients. Add Med Sci. 2015;60(1):64-8. DOI: 10.1016/j.advms.2014.10.00510.1016/j.advms.2014.10.00525437350]Search in Google Scholar
[17. Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 2003;63(15):4327-30.]Search in Google Scholar
[18. Xia B, Yu YH, Guo QS, Li XY, Jiang L, Li J. Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients. World J Gastroenterol. 2005;11(3):415-7. DOI: 10.3748/wjg.v11.i3.41510.3748/wjg.v11.i3.415420535115637757]Open DOISearch in Google Scholar
[19. Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L, et al. FASL–844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med. 2005;202(7):967-74. DOI: 10.1084/jem.2005070710.1084/jem.20050707]Open DOISearch in Google Scholar
[20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. DOI: 10.1093/nar/16.3.121510.1093/nar/16.3.1215]Open DOISearch in Google Scholar
[21. Ozel EG, Duran GG, Celik MM, Duran N, Gunesacar R. Fas and Fas ligand gene polymophisims in Turkish patient with Familial Mediterranean Fever. Gene. 2017; 623:29-32. DOI: 10.1016/j.gene.2017.04.03710.1016/j.gene.2017.04.037]Open DOISearch in Google Scholar
[22. Ghoreschi K, Mrowietz U, Röcken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med. 2003;81(8):471-80. DOI: 10.1007/s00109-003-0460-910.1007/s00109-003-0460-9]Open DOISearch in Google Scholar
[23. Allombert-Blaise C, Tamiji S, Mortier L, Fauvel H, Tual M, Delaporte E, et al. Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway. Cell Death Differ. 2003;10(7):850-2. DOI: 10.1038/sj.cdd.440124510.1038/sj.cdd.4401245]Open DOISearch in Google Scholar
[24. Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal. 2003;15(11):983-92. DOI: 10.1016/S0898-6568(03)00093-710.1016/S0898-6568(03)00093-7]Open DOISearch in Google Scholar
[25. Alenzi FQ. The role of apoptotic proteins in patients with systemic lupus erythematosis. Egypt J Immunol. 2009;16(1):107-16.]Search in Google Scholar
[26. Islam Z, Jahan I, Ahammad RU, Shahnaij M, Nahar S, Mohammad QD. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Banladeshi patients with Guillain-Barre syndrome. Plos One. 2018;12;13(2): e0192703.10.1371/journal.pone.0192703580904629432441]Search in Google Scholar
[27. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 1993;69(4):415-29.]Search in Google Scholar
[28. Kim K-M, Lee K, Hong Y-S, Park H-Y. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells. Exp Mol Med. 2000;32(4):246. DOI: 10.1038/emm.2000.4110.1038/emm.2000.4111190279]Open DOISearch in Google Scholar
[29. Asgari R, Mansouri K, Bakhtiari M, Bidmeshkipour A, Yari K, Zadeh FS, Raygani AV. Association of FAS -670 A/G and FASL -844 C/T polymorphisms with idiopathic azospermia in Wertern Iran. Eur J Obstet Gynecol Reprod Biol. 2017; 218: 55-59. DOI: 10.1016/j.ejogrb.2017.09.00310.1016/j.ejogrb.2017.09.00328942044]Open DOISearch in Google Scholar
[30. Park JY, Lee W-K, Jung D-K, Choi J-E, Park T-I, Lee E-B, et al. Polymorphisms in the FAS and FASL Genes and Survival of Early Stage Non–small Cell Lung Cancer. Clin Cancer Res. 2009;15(5):1794-800. DOI: 10.1158/1078-0432.CCR-08-177010.1158/1078-0432.CCR-08-177019240174]Open DOISearch in Google Scholar